Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL)-Reference-Cited by-同舟云学术

Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL)

Published:2017-04-11 Issue:1 Volume:36 Page:56-61
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Park Ji Hyun¹^ORCID,Kim Shin¹,Ryu Jin Sook²,Lee Sang-wook³,Park Chan-sik⁴,Huh Jooryung⁴,Suh Cheolwon¹

Affiliation:

1. Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

2. Nuclear Medicine, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

3. Radiation Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

4. Pathology, Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference33 articles.

1. The role of FDG-PET scans in patients with lymphoma;Seam;Blood,2007

2. Positron emission tomographic scans in lymphoma: convention and controversy;Ansell;Mayo Clin Proc,2012

3. Imaging in staging of malignant lymphoma: a systematic review;Kwee;Blood,2008

4. Revised response criteria for malignant lymphoma;Cheson;J Clin Oncol,2007

5. Use of positron emission tomography for response assessment of lymphoma: aonsensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma;Juweid;J Clin Oncol,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET-Bildgebung;Indolente Lymphome;2023

2. Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma?;Cancers;2022-01-31

3. PET Imaging;Hematologic Malignancies;2021

4. Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era;Scientific Reports;2020-07-15

5. 18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved—A Critical Review;Clinical Lymphoma Myeloma and Leukemia;2020-03